Evaluation of the in vitro activity of daptomycin against 19615 clinical isolates of Gram-positive cocci collected in North American hospitals (2002-2005)

被引:56
|
作者
Pfaller, Michael A.
Sader, Helio S. [1 ]
Jones, Ronald N.
机构
[1] JML Labs, N Liberty, IA 52317 USA
[2] Univ Iowa, Iowa City, IA 52242 USA
[3] Univ Fed Sao Paulo, Div Infect Dis, BR-04023900 Sao Paulo, Brazil
[4] Tufts Univ, Sch Med, Boston, MA 02111 USA
关键词
daptomycin; gram-positive infections; Staphylococcus aureus; susceptibility;
D O I
10.1016/j.diagmicrobio.2006.10.007
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
We evaluated the antimicrobial activity of daptomycin against 19 615 clinical strains consecutively collected by numerous centers located across the United States and Canada (2002-2005). Daptomycin was very active against all indicated species (>99% susceptible), with the highest MIC results being 2, 8, 0.5, and 1 mu g/mL for staphylococci, enterococci, beta-hemolytic streptococci, and viridans group streptococci, respectively, and no significant loss in potency was observed over the period studied. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:459 / 465
页数:7
相关论文
共 50 条
  • [41] In Vitro Antimicrobial Activity of Diacerein on 76 Isolates of Gram-Positive Cocci from Bacterial Keratitis Patients and In Vivo Study of Diacerein Eye Drops on Staphylococcus aureus Keratitis in Mice
    Zhang, Hongmin
    Liu, Susu
    Yue, Juan
    Sun, Shengtao
    Lv, Qixue
    Jian, Shoujun
    Xie, Yanting
    Han, Lei
    Zhang, Fenfen
    Dai, Yanfang
    Wang, Liya
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2019, 63 (04)
  • [42] Comparative in vitro activity of tigecycline and other antimicrobials against Gram-negative and Gram-positive organisms collected from the Asia-Pacific Rim as part of the Tigecycline Evaluation and Surveillance Trial (TEST)
    Bouchillon, Sam K.
    Iredell, Jonathan R.
    Barkham, Timothy
    Lee, Kyungwon
    Dowzicky, Michael J.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2009, 33 (02) : 130 - 136
  • [43] Comparative in vitro activity of ceftaroline and comparator agents against nosocomial Gram-negative and Gram-positive clinically significant bacterial isolates from patients in a teaching hospital in Kuwait
    Jamal, Wafaa
    Abdulkareem, Hayfaa
    Rotimi, Vincent O.
    JOURNAL OF CHEMOTHERAPY, 2018, 30 (04) : 213 - 223
  • [44] In vitro activity of tigecycline and comparator agents against a global collection of Gram-negative and Gram-positive organisms: Tigecycline Evaluation and Surveillance Trial 2004 to 2007
    Garrison, Mark W.
    Mutters, Reinier
    Dowzicky, Michael J.
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2009, 65 (03) : 288 - 299
  • [45] In vitro activity of ceftazidime/avibactam and comparators against Gram-negative bacterial isolates collected from Latin American centres between 2015 and 2017
    Stone, Gregory G.
    Ponce-de-Leon, Alfredo
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2020, 75 (07) : 1859 - 1873
  • [46] Five-Year Summary of In Vitro Activity and Resistance Mechanisms of Linezolid against Clinically Important Gram-Positive Cocci in the United States from the LEADER Surveillance Program (2011 to 2015)
    Pfaller, Michael A.
    Mendes, Rodrigo E.
    Streit, Jennifer M.
    Hogan, Patricia A.
    Flamm, Robert K.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2017, 61 (07)
  • [47] Activities of Tedizolid and Linezolid Determined by the Reference Broth Microdilution Method against 3,032 Gram-Positive Bacterial Isolates Collected in Asia-Pacific, Eastern Europe, and Latin American Countries in 2014
    Pfaller, Michael A.
    Flamm, Robert K.
    Jones, Ronald N.
    Farrell, David J.
    Mendes, Rodrigo E.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (09) : 5393 - 5399
  • [48] In vitro activities of tedizolid compared with other antibiotics against Gram-positive pathogens associated with hospital-acquired pneumonia, skin and soft tissue infection and bloodstream infection collected from 26 hospitals in China
    Li, Shuguang
    Guo, Yu
    Zhao, Chunjiang
    Chen, Hongbin
    Hu, Bijie
    Chu, Yunzhuo
    Zhang, Zhijie
    Hu, Yunjian
    Liu, Zhiyong
    Du, Yan
    Gui, Qiaodi
    Ji, Ping
    Zeng, Ji
    Cao, Bin
    Fu, Quan
    Zhang, Rong
    Wang, Zhongxin
    Zhuo, Chao
    Feng, Xianju
    Jia, Wei
    Jin, Yan
    Xu, Xuesong
    Liao, Kang
    Ni, Yuxing
    Yu, Yunsong
    Xu, Xiuli
    Hu, Zhidong
    Lei, Jin-e
    Yang, Qing
    Wang, Hui
    JOURNAL OF MEDICAL MICROBIOLOGY, 2016, 65 : 1215 - 1224
  • [49] Trending 7 years of in vitro activity of tigecycline and comparators against Gram-positive and Gram-negative pathogens from the Asia-Pacific region: Tigecycline Evaluation Surveillance Trial (TEST) 2004-2010
    Hawser, Stephen P.
    Bouchillon, Samuel K.
    Hackel, Meredith
    Chen, Minjun
    Kim, Eui-Chong
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2012, 39 (06) : 490 - 495
  • [50] In Vitro Activity of Cefepime-Taniborbactam and Comparators against Clinical Isolates of Gram-Negative Bacilli from 2018 to 2020: Results from the Global Evaluation of Antimicrobial Resistance via Surveillance (GEARS) Program
    Karlowsky, James A.
    Hackel, Meredith A.
    Wise, Mark G.
    Six, David A.
    Uehara, Tsuyoshi
    Daigle, Denis M.
    Cusick, Susan M.
    Pevear, Daniel C.
    Moeck, Greg
    Sahm, Daniel F.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2023, 67 (01)